読み込み中
AMEXHealthcareDrug Manufacturers - Specialty & Generic
最新データ
$0.3899
−$0.0049 · -1.24%
cbdMD, Inc. is engaged in the production and distribution of a diverse array of cannabidiol (CBD) products. The company oversees and markets several consumer-oriented, hemp-derived CBD brands, notably its primary brand cbdMD, alongside Paw CBD and cbdMD Botanicals. Under the cbdMD label, its offerings span various items, including CBD tinctures, edible gummies, topical applications, capsules, bath bombs, bath salts, and solutions designed to aid sleep. Furthermore, its Paw CBD brand caters to pets with veterinarian-formulated products such as tinctures, edible chews, and topical treatments. The company's merchandise reaches customers throughout the United States via its proprietary e-commerce platform, various third-party online retail sites, wholesale partners, and physical brick-and-mortar establishments. cbdMD, Inc. also maintains a research collaboration with the University of Mississippi, focusing on the discovery of novel cannabinoids. Incorporated in 2015, the firm was previously known as Level Brands, Inc. before officially changing its name to cbdMD, Inc. in May 2019, and its corporate headquarters are situated in Charlotte, North Carolina.
前日終値
$0.3899
−$0.0049 · -1.24%
日中の時刻はETです。市場データは遅延する場合があります。
cbdMD, Inc. is engaged in the production and distribution of a diverse array of cannabidiol (CBD) products. The company oversees and markets several consumer-oriented, hemp-derived CBD brands, notably its primary brand cbdMD, alongside Paw CBD and cbdMD Botanicals. Under the cbdMD label, its offerings span various items, including CBD tinctures, edible gummies, topical applications, capsules, bath bombs, bath salts, and solutions designed to aid sleep. Furthermore, its Paw CBD brand caters to pets with veterinarian-formulated products such as tinctures, edible chews, and topical treatments. The company's merchandise reaches customers throughout the United States via its proprietary e-commerce platform, various third-party online retail sites, wholesale partners, and physical brick-and-mortar establishments. cbdMD, Inc. also maintains a research collaboration with the University of Mississippi, focusing on the discovery of novel cannabinoids. Incorporated in 2015, the firm was previously known as Level Brands, Inc. before officially changing its name to cbdMD, Inc. in May 2019, and its corporate headquarters are situated in Charlotte, North Carolina.
日中レンジ
現在 $0.3899
52週レンジ
現在 $0.3899
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
売り
バリュエーション
48
適正価値
センチメント
66
強気
リスク
79
高リスク
モメンタム
35
弱含み
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
cbdMD, Inc. is engaged in the production and distribution of a diverse array of cannabidiol (CBD) products. The company oversees and markets several consumer-oriented, hemp-derived CBD brands, notably its primary brand cbdMD, alongside Paw CBD and cbdMD Botanicals. Under the cbdMD label, its offerings span various items, including CBD tinctures, edible gummies, topical applications, capsules, bath bombs, bath salts, and solutions designed to aid sleep. Furthermore, its Paw CBD brand caters to pets with veterinarian-formulated products such as tinctures, edible chews, and topical treatments. The company's merchandise reaches customers throughout the United States via its proprietary e-commerce platform, various third-party online retail sites, wholesale partners, and physical brick-and-mortar establishments. cbdMD, Inc. also maintains a research collaboration with the University of Mississippi, focusing on the discovery of novel cannabinoids. Incorporated in 2015, the firm was previously known as Level Brands, Inc. before officially changing its name to cbdMD, Inc. in May 2019, and its corporate headquarters are situated in Charlotte, North Carolina.
日中レンジ
現在 $0.3899
52週レンジ
現在 $0.3899
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標（USD） | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2021年度 |
|---|---|---|---|---|---|
| 売上高 | 1919.05万 USD | 1948.22万 USD | 2415.54万 USD | 3540.32万 USD | 4448.08万 USD |
| 売上原価 | 722.22万 USD | 863.65万 USD | 1111.88万 USD | 1490万 USD | 1551.25万 USD |
| 粗利益 | 1196.83万 USD | 1084.57万 USD | 1303.65万 USD | 2050.33万 USD | 2896.83万 USD |
| 研究開発 | 3.39万 USD | — | — | — | — |
| 販売・一般管理 | 1143.42万 USD | 1403.53万 USD | 2230.51万 USD | 3781.38万 USD | 4858.43万 USD |
| 営業費用 | 1413.08万 USD | 1403.53万 USD | 2230.51万 USD | 3781.38万 USD | 4858.43万 USD |
| 受取利息 | 3.43万 USD | — | 6.37万 USD | 1.62万 USD | — |
| 支払利息 | — | 2.95万 USD | — | — | 2.89万 USD |
| 減価償却費と償却費 | 179.59万 USD | 182.05万 USD | 292.77万 USD | 297.05万 USD | 225.38万 USD |
| 営業利益 | −216.26万 USD | −318.96万 USD | −926.85万 USD | −1731.05万 USD | −1961.6万 USD |
| 純利益 | −204.09万 USD | −370.01万 USD | −2293.82万 USD | −7008.37万 USD | −2339.49万 USD |
会社概要が更新されました 2026年10月11日.
直近の発表実績
直近の発表実績
第三者のアナリスト予想は変更される場合があり、GoAIの推奨ではありません。
評価サンプルは3件と限定的です
| 種別 | 発効日 | 詳細 | 基準日 | 支払日 |
|---|---|---|---|---|
株式分割 | 2025年5月7日 | 1:8 | — | — |
株式分割 | 2023年4月25日 | 1:45 | — | — |
発効済み 2025年5月7日
1:8
発効済み 2023年4月25日
1:45
この株式へのエクスポージャーを報告している上場投資信託です。
AIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。
